Skip to content
Home/Companies/Industrials/Biosynthetic Technologies

Biosynthetic Technologies

Industrials·United States·Exited 2018·Held 4yr
Entry
2014
Hold
4yr
Exit
2018

Who owns Biosynthetic Technologies?

Biosynthetic Technologies was owned by Evonik Venture Capital through Evonik Venture Capital (2012 vintage) from 2014 to 2018, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-10

Evonik Venture Capital
Investor
Evonik Venture Capital
Evonik Venture Capital · 2012 · VC

Key facts

HQUnited States
SectorIndustrials
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2018

More from Evonik Venture Capital

Other portfolio companies in the same fund.

Abolis
Active
BiotechFrance· 2024
JLand Biotech
Active
BiotechChina· 2024
Interface Polymers
Interface Polymers
Active
IndustrialsUnited Kingdom· 2023
SuperC
Active
ClimateTechChina· 2023
Allay Therapeutics
Allay Therapeutics
Active
MedTechUnited States· 2022
Biograil
Biograil
Active
MedTechDenmark· 2022

More PE-backed in Industrials

Comparable industrials deals from other GPs.

3bee 2
Active
AgFunderUS
48forty Solutions
48forty Solutions
Active
Summit PartnersUS
A man in a warehouse
Active
Partners Group
A person welding something
Active
Partners Group
A-Gas
A-Gas
Active
TPG EuropeUK
ABB E-Mobility
ABB E-Mobility
Active
General AtlanticSwitzerland
Track Biosynthetic Technologies

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Biosynthetic Technologies.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue